StreetInsider.com News Articles

Vortex Energy Announces Plans for Ground Gravity Survey at the Robinsons River Salt Project

Thu, 03 Sep 2026 08:00:00 -0400

VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce plans to undertake a targeted ground gravity survey at its 100%-owned Robinsons River Salt Project (the “Project”), located approximately 35 kilometres south of Stephenville, Newfoundland and Labrador. The survey has been selected as the Company’s next geophysical program at the Project.

The program builds upon the technical study results announced by the Company on August 6, 2026. That study integrated the available geological, drilling, seismic and gravity information and

Vortex Energy Announces Plans for Ground Gravity Survey at the Robinsons River Salt Project

Thu, 03 Sep 2026 08:00:00 -0400

The program builds upon the technical study results announced by the Company on August 6, 2026. That study integrated the available geological, drilling, seismic and gravity information and

Morgan Stanley Resumes Vertex (VRTX) at Overweight

Tue, 01 Sep 2026 16:48:16 -0400

Morgan Stanley analyst Terence Flynn resumes coverage on Vertex (NASDAQ: VRTX) with a Overweight rating and a price target of $665.00.

For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.

Shares of Vertex closed at $544.52 yesterday.

Goldman Sachs refreshes conviction lists on both sides of the Atlantic

Tue, 01 Sep 2026 13:41:01 -0400

Investing.com -- Goldman Sachs updated its U.S. and European conviction lists for September, adding several new names as it refreshed its highest-conviction ideas heading into the autumn.

In the U.S., the bank added Vertex Pharmaceuticals while removing Interactive Brokers, leaving the list at 23 names.

Analyst Salveen Richter believes the large-cap biotech is "well-positioned for long-term growth as it executes against potentially up to five, multi-billion dollar opportunities" spanning cystic fibrosis, pain, kidney disease and hematology, with a proposed acquisition of Crinetics establishing a fifth pillar in endocrinology.

Other U.S. names on the list include Estée Lauder, Wells Fargo,

Goldman Sachs refreshes conviction lists on both sides of the Atlantic

Tue, 01 Sep 2026 13:41:01 -0400

Investing.com -- Goldman Sachs updated its U.S. and European conviction lists for September, adding several new names as it refreshed its highest-conviction ideas heading into the autumn.

In the U.S., the bank added Vertex Pharmaceuticals while removing Interactive Brokers, leaving the list at 23 names.

Other U.S. names on the list include Estée Lauder, Wells Fargo,

Goldman Sachs refreshes conviction lists on both sides of the Atlantic

Tue, 01 Sep 2026 13:41:01 -0400

Investing.com -- Goldman Sachs updated its U.S. and European conviction lists for September, adding several new names as it refreshed its highest-conviction ideas heading into the autumn.

In the U.S., the bank added Vertex Pharmaceuticals while removing Interactive Brokers, leaving the list at 23 names.

Other U.S. names on the list include Estée Lauder, Wells Fargo,

Goldman Sachs Adjust Monthly US Director's Cut List

Tue, 01 Sep 2026 05:31:33 -0400

Goldman Sachs Adjust Monthly US Director's Cut List.

Adds: Vertex Pharma (NASDAQ: VRTX)
Removes: Interactive Brokers (NASDAQ: IBKR)

The Director's List for the US explained by Goldman and how it's started: "On June 1, 2023 we introduced this new investment list which highlights a selection of fundamental Buy-rated US stocks across the Goldman Sachs Americas Global Investment Research department. These ideas are sourced from our US research analysts, but chosen by members of our Investment Review Committee. This new ‘Conviction List - Directors’ Cut’ is designed to provide investors with a curated and active list of 20-25 of what we believe to be

Goldman Sachs Adjust Monthly US Director's Cut List

Tue, 01 Sep 2026 05:31:33 -0400

Goldman Sachs Adjust Monthly US Director's Cut List.

Adds: Vertex Pharma (NASDAQ: VRTX)
Removes: Interactive Brokers (NASDAQ: IBKR)

Form 144 VERTEX PHARMACEUTICALS Filed by: SACHS BRUCE I

Thu, 27 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260827/26990765.html

Form 144 VERTEX PHARMACEUTICALS Filed by: SACHS BRUCE I

Thu, 27 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260827/26990765.html

Vertex to Participate in Upcoming September Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in four upcoming investor conferences.

Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 4:30 p.m. EDT.
Susie Lisa and Manisha Pai will also participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 2:10 p.m. EDT.
Reshma Kewalramani, M.D., CEO and President, will participate in a fireside chat

Vertex to Participate in Upcoming September Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in four upcoming investor conferences.

Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 4:30 p.m. EDT.
Susie Lisa and Manisha Pai will also participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 2:10 p.m. EDT.
Reshma Kewalramani, M.D., CEO and President, will participate in a fireside chat

Vertex to Participate in Upcoming September Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in four upcoming investor conferences.

Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 4:30 p.m. EDT.
Susie Lisa and Manisha Pai will also participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 2:10 p.m. EDT.
Reshma Kewalramani, M.D., CEO and President, will participate in a fireside chat

Vertex to Participate in Upcoming September Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in four upcoming investor conferences.

Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 4:30 p.m. EDT.
Susie Lisa and Manisha Pai will also participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 2:10 p.m. EDT.
Reshma Kewalramani, M.D., CEO and President, will participate in a fireside chat

Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project